Ars Investment Partners, LLC Exact Sciences Corp Transaction History

Ars Investment Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$93.66 - $139.27 $145,641 - $216,564	-1,555 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$116.57 - $155.01 $445,880 - $592,913	-3,825 Reduced 71.1%	1,555 $205,000
Q4 2020 Feb 09, 2021	SELL	$99.61 - $142.12 $168,340 - $240,182	-1,690 Reduced 23.9%	5,380 $713,000
Q3 2020 Nov 12, 2020	SELL	$72.92 - $102.01 $12.6 Million - $17.7 Million	-173,321 Reduced 96.08%	7,070 $721,000
Q2 2020 Aug 13, 2020	SELL	$55.75 - $92.75 $141,660 - $235,677	-2,541 Reduced 1.39%	180,391 $15.7 Million
Q1 2020 May 12, 2020	SELL	$37.9 - $104.44 $1.19 Million - $3.29 Million	-31,472 Reduced 14.68%	182,932 $10.6 Million
Q4 2019 Feb 12, 2020	BUY	$77.66 - $99.74 $8.02 Million - $10.3 Million	103,285 Added 92.95%	214,404 $19.8 Million
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $8.15 Million - $11 Million	90,144 Added 429.77%	111,119 $10 Million
Q2 2019 Aug 12, 2019	BUY	$89.51 - $118.04 $904,051 - $1.19 Million	10,100 Added 92.87%	20,975 $2.48 Million
Q1 2019 May 09, 2019	BUY	$61.98 - $96.5 $674,032 - $1.05 Million	10,875 New	10,875 $942,000

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.1B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Ars Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ars Investment Partners, LLC with notifications on news.